TIME

FDA Approves Emergency Use of Antibody Drug Trump Received to Treat COVID-19

11.23.2020 - By TimePlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

U.S. health officials Saturday agreed to allow emergency use of a second antibody drug to help the immune system fight COVID-19, an experimental medicine that President Donald Trump was given when he was sickened last month.

The Food and Drug Administration authorized use of the Regeneron Pharmaceuticals Inc. drug to try to prevent hospitalization and worsening disease from developing in patients with mild-to-moderate symptoms.

The drug is given as a one-time treatment through an IV.

More episodes from TIME